FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Leiter's Enterprises Cefuroxime 10 mg/mL in Sodium Chloride Recall

Cefuroxime 10 mg/mL in Sodium Chloride, Intravitreal injection, 1 mL in a 2mL Vial, Oph…

Leiter's Enterprises, Inc. · San Jose, CA

Risk level
Class II
Reported by FDA
Mar 13, 2019
Recall ID
D-0518-2019
Check your lot numberHow we source this data

Summary

Leiter's Enterprises recalled Cefuroxime 10 mg/mL in Sodium Chloride starting Feb 19, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0518-2019 on Mar 13, 2019. Reason: Incorrect Product Formulation; compounded sterile drug reconstituted using sterile water instead of sterile 0.9% Sodium Chloride. Status: Terminated.

Why it was recalled

Incorrect Product Formulation; compounded sterile drug reconstituted using sterile water instead of sterile 0.9% Sodium Chloride.

Product description

Cefuroxime 10 mg/mL in Sodium Chloride, Intravitreal injection, 1 mL in a 2mL Vial, Ophthalmic Use Only, Office Use Only, Leiter's (800) 292-6772- 17 Great Oaks Blvd., San Jose, CA 95119. NDC: 70360-007-35.

Lot numbers, UPCs & expiration codes

Lot # 1811195, Exp. Date: 05/01/19

Where it was sold

CA, AZ, MI, NY

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0518-2019
Classification
Class II
Status
Terminated
Recall initiated
Feb 19, 2019
FDA report date
Mar 13, 2019
Quantity
569 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Leiter's Enterprises, Inc.

Original FDA data

Every field from FDA enforcement report D-0518-2019, exactly as published.

Show all FDA fields
City
San Jose
State
CA
Status
Terminated
Country
United States
Event ID
82229
Address
17 Great Oaks Blvd
Code information
Lot # 1811195, Exp. Date: 05/01/19
Postal code
95119-1359
Report date
Mar 13, 2019
Product type
Drugs
Recall number
D-0518-2019
Classification
Class II
Recalling firm
Leiter's Enterprises, Inc.
Product quantity
569 vials
Termination date
Feb 26, 2020
Reason for recall
Incorrect Product Formulation; compounded sterile drug reconstituted using sterile water instead of sterile 0.9% Sodium Chloride.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cefuroxime 10 mg/mL in Sodium Chloride, Intravitreal injection, 1 mL in a 2mL Vial, Ophthalmic Use Only, Office Use Only, Leiter's (800) 292-6772- 17 Great Oaks Blvd., San Jose, CA 95119. NDC: 70360-007-35.
Distribution pattern
CA, AZ, MI, NY
Recall initiation date
Feb 19, 2019
Initial firm notification
Telephone
Center classification date
Mar 6, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0518-2019, published Mar 13, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls